Retinopathy of prematurity

被引：59

作者：

Dammann, Olaf ^{[1
,2
,3
]}

Hartnett, M. Elizabeth ^{[4
]}

Stahl, Andreas ^{[5
]}

机构：

[1] Tufts Univ, Dept Publ Hlth & Community Med, Sch Med, Boston, MA 02111 USA

[2] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany

[3] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway

[4] Univ Utah Hlth, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA

[5] Univ Med Greifswald, Dept Ophthalmol Greifswald, Mecklenburg Vorpommern, Germany

来源：

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY | 2023年 / 65卷 / 05期

关键词：

BEVACIZUMAB; BORN; RANIBIZUMAB; MECHANISMS; EFFICACY; OUTCOMES; THERAPY; INFANTS; SAFETY;

D O I：

10.1111/dmcn.15468

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Retinopathy of prematurity (ROP) is a devastating neurovascular disease of the retina in newborn infants that can lead to vision deficits or even blindness. In this concise review we discuss our current knowledge about diagnosis, etiology, pathogenesis, intervention, and outcomes of the disease. Major advancements have been made both in categorizing the disease in the new International Classification of Retinopathy of Prematurity, Third Edition classification and in treating severe ROP with anti-vascular endothelial growth factor (VEGF) agents. New development always creates new questions and opens up new areas of research. We will discuss in this review both the benefits and downsides of the new anti-VEGF treatment approaches in ROP, especially in light of our improved understanding of the underlying ROP pathophysiology. We also offer pointers to areas where more research is needed.

引用

收藏

页码：625 / 631

页数：7

相关论文

共 65 条

[1] The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity [J].

Ahmed, Shahanaz B. ;

Higham, Aisling ;

Mulvihill, Alan ;

Chan, T. K. J. ;

Adams, Gill ;

Patel, Chetan K. .

EYE, 2021, 35 (09) :2451-2453

[2] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].

AIELLO, LP ;

PIERCE, EA ;

FOLEY, ED ;

TAKAGI, H ;

CHEN, H ;

RIDDLE, L ;

FERRARA, N ;

KING, GL ;

SMITH, LEH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461

[3] Addressing the Third Epidemic of Retinopathy of Prematurity Through Telemedicine and Technology: A Systematic Review [J].

Al-Khaled, Tala ;

Valikodath, Nita G. ;

Patel, Samir N. ;

Cole, Emily ;

Chervinko, Margaret ;

Douglas, Christina E. ;

Tsai, Andrew S. H. ;

Wu, Wei-Chi ;

Campbell, J. Peter ;

Chiang, Michael F. ;

Chan, R. V. Paul .

JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2021, 58 (04) :261-+

[4] Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity [J].

Arima, Mitsuru ;

Akiyama, Masato ;

Fujiwara, Kohta ;

Mori, Yujiro ;

Inoue, Hirosuke ;

Seki, Eiko ;

Nakama, Takahito ;

Tsukamoto, Shoko ;

Ochiai, Masayuki ;

Ohga, Shouichi ;

Sonoda, Koh-Hei .

PLOS ONE, 2020, 15 (03)

[5] Antenatal IL-1-dependent inflammation persists postnatally and causes retinal and sub-retinal vasculopathy in progeny [J].

Beaudry-Richard, Alexandra ;

Nadeau-Vallee, Mathieu ;

Prairie, Elizabeth ;

Maurice, Noemie ;

Heckel, Emilie ;

Nezhady, Mohammad ;

Pundir, Sheetal ;

Madaan, Ankush ;

Boudreault, Amarilys ;

Hou, Xin ;

Quiniou, Christiane ;

Sierra, Estefania Marin ;

Beaulac, Alexandre ;

Lodygensky, Gregory ;

Robertson, Sarah A. ;

Keelan, Jeffrey ;

Adams-Waldorf, Kristina ;

Olson, David M. ;

Rivera, Jose-Carlos ;

Lubell, William D. ;

Joyal, Jean-Sebastien ;

Bouchard, Jean-Francois ;

Chemtob, Sylvain .

SCIENTIFIC REPORTS, 2018, 8

[6] Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010 [J].

Blencowe, Hannah ;

Lawn, Joy E. ;

Vazquez, Thomas ;

Fielder, Alistair ;

Gilbert, Clare .

PEDIATRIC RESEARCH, 2013, 74 :35-49

[7] Early and late onset sepsis and retinopathy of prematurity in a cohort of preterm infants [J].

Bonafiglia, Elena ;

Gusson, Elena ;

Longo, Rosa ;

Ficial, Benjamim ;

Tisato, Maria Giulia ;

Rossignoli, Sara ;

Caltran, Giulia ;

Pedrotti, Emilio ;

Beghini, Renzo ;

Marchini, Giorgio .

SCIENTIFIC REPORTS, 2022, 12 (01)

[8] Erythropoietin Receptor Signaling Supports Retinal Function after Vascular Injury [J].

Bretz, Colin A. ;

Simmons, Aaron B. ;

Kunz, Eric ;

Ramshekar, Aniket ;

Kennedy, Carson ;

Cardenas, Ivan ;

Hartnett, M. Elizabeth .

AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (03) :630-641

[9] IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants [J].

Cakir, Bertan ;

Hellstrom, William ;

Tomita, Yohei ;

Fu, Zhongjie ;

Liegl, Raffael ;

Winberg, Anna ;

Hansen-Pupp, Ingrid ;

Ley, David ;

Hellstrom, Ann ;

Lofqvist, Chatarina ;

Smith, Lois E. H. .

JCI INSIGHT, 2020, 5 (19)

[10] Applications of Artificial Intelligence for Retinopathy of Prematurity Screening [J].

Campbell, J. Peter ;

Singh, Praveer ;

Redd, Travis K. ;

Brown, James M. ;

Shah, Parag K. ;

Subramanian, Prema ;

Rajan, Renu ;

Valikodath, Nita ;

Cole, Emily ;

Ostmo, Susan ;

Chan, R. V. Paul ;

Venkatapathy, Narendran ;

Chiang, Michael F. ;

Kalpathy-Cramer, Jayashree .

PEDIATRICS, 2021, 147 (03)

← 1 2 3 4 5 6 7 →